A detailed history of Putnam Investments LLC transactions in Surmodics Inc stock. As of the latest transaction made, Putnam Investments LLC holds 10,628 shares of SRDX stock, worth $409,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,628
Previous 11,989 11.35%
Holding current value
$409,815
Previous $384,000 0.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $38,747 - $52,384
-1,361 Reduced 11.35%
10,628 $386,000
Q3 2023

Nov 14, 2023

BUY
$28.28 - $38.36 $339,048 - $459,898
11,989 New
11,989 $384,000
Q2 2022

Aug 15, 2022

SELL
$33.25 - $45.11 $234,578 - $318,251
-7,055 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$40.68 - $49.72 $21,438 - $26,202
-527 Reduced 6.95%
7,055 $320,000
Q4 2021

Feb 14, 2022

BUY
$43.21 - $57.6 $327,618 - $436,723
7,582 New
7,582 $365,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $540M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.